Nutritrace (Sodium Molybdate Dihydrate, Zinc Chloride, Chromic Chloride, Copper Chloride, Ferrous Chloride, Mang)

NutriTrace is used in clinical nutrition to address deficiencies of trace elements that are essential for enzymatic activity and metabolic pathways.

• Copper deficiency: helps restore normal copper‑dependent enzymatic functions.
• Zinc deficiency: contributes to immune competence and protein synthesis.
• Iron (ferrous) deficiency: supports hemoglobin formation.
• Molybdenum and chromium supplementation: aids enzymes involved in sulfur‑amino‑acid metabolism and glucose regulation.
• General parenteral nutrition: provides a balanced trace‑element profile for patients on long‑term IV nutrition.

• NutriTrace delivers a combination of essential trace elements—molybdenum, zinc, chromium, copper, and iron—directly into the bloodstream, bypassing gastrointestinal absorption. These minerals act as cofactors for a variety of oxidoreductase and metallo‑enzyme systems, facilitating catalytic activity in metabolic pathways such as amino‑acid catabolism, oxidative phosphorylation, and glucose utilization.

Adverse reactions to NutriTrace are generally related to the individual trace elements and the intravenous route.

Common Side Effects

• Mild fever or chills during infusion.
• Localized redness or irritation at the injection site.
• Transient headache.
• Nausea or mild gastrointestinal upset.
• Slight elevation of liver enzymes.

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reaction.
• Acute hemolysis or hemoglobinuria.
• Significant electrolyte imbalance (e.g., copper overload).
• Renal impairment secondary to metal accumulation.
• Severe thrombophlebitis at the infusion site.

When using NutriTrace, clinicians should observe standard safety measures for intravenous trace‑element solutions.

• Dose individualisation: adjust based on laboratory‑monitored trace‑element levels.
• Renal function: assess before initiation and monitor periodically.
• Hepatic function: check liver enzymes, especially with copper and iron components.
• Compatibility: verify compatibility with other IV fluids and medications.
• Monitoring: observe patients for signs of hypersensitivity during and after infusion.
• Store at ambient temperature: keep in original packaging, protect from light and moisture.

NutriTrace may interact with other medications or solutions that affect trace‑element status or metal metabolism.

Major Interactions (Avoid)

• Chelating agents (e.g., deferoxamine, EDTA) that bind copper, iron or zinc and markedly reduce efficacy.
• High‑dose vitamin C infusions that can increase iron absorption and risk of oxidative stress.

Moderate Interactions (Monitor Closely)

• Antibiotics such as tetracyclines or fluoroquinolones that can chelate zinc and reduce its bioavailability.
• Loop diuretics that increase urinary excretion of zinc and copper.
• Parenteral lipid emulsions that may affect the stability of the trace‑element solution.
• Blood products transfused concurrently, which can alter measured trace‑element levels.